Literature DB >> 2302410

Identification of furoyl-containing advanced glycation products in collagen samples from diabetic and healthy rats.

A Lapolla1, C Gerhardinger, E Ghezzo, R Seraglia, A Sturaro, G Crepaldi, D Fedele, P Traldi.   

Abstract

The compounds resulting from the reaction of glucose with proteins (advanced glycation products) can be important markers of chronic diabetic complications. To test the possible diagnostic value of advanced glycation products containing the furoyl moiety, collagen samples from diabetic and healthy rats were analyzed by parent ion spectroscopy. In our study, we compared normal collagen, diabetic collagen and normal collagen incubated with different glucose concentrations and we employed different hydrolysis procedures (HCl and proteinase). Mass spectroscopic measurements performed on hydrolyzed samples showed that either different samples or different hydrolysis procedures produce a similar set of furoyl-containing compounds. 2-(2-Furoyl)-4(5)-(2-furanyl)-1H-imidazole (FFI) which has been reported to be one of the advanced glycation products, was never found in any of the samples examined. Hence neither FFI nor furoyl-containing molecules can be considered markers of advanced glycation processes.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2302410     DOI: 10.1016/0304-4165(90)90187-2

Source DB:  PubMed          Journal:  Biochim Biophys Acta        ISSN: 0006-3002


  3 in total

1.  Studies on advanced glycation end products by recent mass spectrometric techniques.

Authors:  A Lapolla; D Fedele; P Traldi
Journal:  Amino Acids       Date:  1994-02       Impact factor: 3.520

2.  Colorimetric versus radioimmunological measurement of glycated and non-glycated serum albumin after affinity chromatography.

Authors:  L Cruschelli; A Clerico; G Penno; R Navalesi; O Giampietro
Journal:  Acta Diabetol Lat       Date:  1990 Oct-Dec

3.  Processing of type I collagen gels using nonenzymatic glycation.

Authors:  Rani Roy; Adele Boskey; Lawrence J Bonassar
Journal:  J Biomed Mater Res A       Date:  2010-06-01       Impact factor: 4.396

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.